Author

S. E. Lawler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. P. Droop· 1 shared A. Sheen· 1 shared A. Stafford· 1 shared A. Tabet· 1 shared B. da Silva· 1 shared C. Apra· 1 shared D. A. Barbie· 1 shared D. C. Tomlinson· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. P. Droop

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Reprogramming brain immunosurveillance with engineered cytokines

A. Tabet, Y. Agarwal, J. Stinson, C. Apra, V. Will, M. Manthey, N. Momin, A. Sheen, M. Murdock, L. Santollani, L.-H. Tsai, I. Chiu, S. E. Lawler, D. J. Irvine, K. D. Wittrup, P. Anikeeva

This study shows engineered cytokines can reprogram brain immunosurveillance by extending their residence time in the brain using alum scaffolds, delaying tumor progression in mouse models.

bioRxiv · Jun 21, 2022 · PreprintBioengineering

STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models

G. Berger, E. H. Knelson, J. L. Jimenez-Macias, M. O. Nowicki, S. Han, P. H. Lizotte, K. Adu-Berchie, A. Stafford, N. Dimitrikakis, E. A. Chiocca, D. J. Mooney, D. A. Barbie, S. E. Lawler

This study shows that STING activation in glioblastoma models enhances immune responses and NK cell-mediated tumor regression, with long-term survival benefits in murine models.

bioRxiv · Feb 28, 2022 · PreprintCancer Biology

A high-content screen profiles cytotoxic microRNAs in pediatric and adult glioblastoma cells and identifies miR-1300 as a potent inducer of cytokinesis failure

M. Boissinot, H. King, M. Adams, J. Higgins, T. A. Ward, L. P. Steele, D. Tams, R. Morton, E. Polson, B. da Silva, A. P. Droop, J. L. Hayes, H. Martin, P. Laslo, E. E. Morrison, , S. C. Short

This study identifies miR-1300 as a potent cytotoxic microRNA in glioblastoma cells, causing cytokinesis failure and apoptosis, with potential therapeutic applications.

bioRxiv · Oct 1, 2019 · PreprintCancer Biology